Concepedia

Kirsten Kaiser

KK

Statistics

Publications

7

Citations

200

H-Index

7

Active since

2012

Affiliations

Mundipharma (United Kingdom)(Current)

Dnipro State Medical University

Kharkiv Regional Clinical Psychiatric Hospital No 3

University of Ferrara

Heartlands Hospital

Kirsten Kaiser is an author at Mundipharma (United Kingdom) specializing in asthma management, pharmacy, and asthma pharmacotherapy.

Publications per year

2012–2016

7

Publications

7

Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma

Jonathan Corren, Lyndon E. Mansfield, Tetyana Pertseva et al. · Respiratory Medicine · 2012 · 52 citations · Full text

, , +9

Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial

Robert A. Nathan, Anthony D’Urzo, Viktor Blazhko et al. · BMC Pulmonary Medicine · 2012 · 35 citations · Full text

, , +17

Long-Term Safety and Efficacy of Fluticasone/Formoterol Combination Therapy in Asthma

Adel Mansur, Kirsten Kaiser · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2012 · 30 citations

, , +13

Superiority of fluticasone propionate/formoterol fumarate versus fluticasone propionate alone in patients with moderate-to-severe asthma: a randomised controlled trial

Tetyana Pertseva, Sanjeeva Dissanayake, Kirsten Kaiser · Current Medical Research and Opinion · 2013 · 27 citations

, , +17

Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations

Alberto Papi, Adel Mansur, Tetyana Pertseva et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2016 · 25 citations · Full text

, , +14

1–5 of 7